A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

NCT03922945 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Adolescent Obesity
Obesity in Adolescence
Adolescent Overweight

Interventions

DRUG: VI-0521 oral capsule
DRUG: Placebo oral capsule
BEHAVIORAL: Lifestyle Modification

Sponsor

VIVUS LLC